Therapeutic targets of arsenic trioxide in lymphoma treatment
Lymphomas are malignant diseases involving the lymphatic system. Arsenic trioxide (As2O3) is a current therapeutic agent for acute promyelocytic leukaemia (APL).APL cells are sensitive to As2O3, with As2O3directly targeting the PML-RARA protein that plays an important role in the oncogenesis of APL....
Main Authors: | , |
---|---|
Other Authors: | |
Language: | English |
Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/10722/197540 |